RBC Capital raised the firm's price target on Cameco to C$175 from C$160 and keeps an Outperform rating on the shares. Cameco is well positioned to benefit from improving uranium pricing dynamics and growing nuclear demand, supported by strong sovereign and utility buying interest, higher-than-reported contract pricing, and favorable U.S. and Canadian policy support for nuclear reactor deployment, the analyst tells investors in a research note.
